Related references
Note: Only part of the references are listed.Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies
Alan S. Lewis et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia
Dalton King et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia
Linda J. Bristow et al.
PLOS ONE (2016)
Differential effects of α7 nicotinic receptor agonist PHA-543613 on spatial memory performance of rats in two distinct pharmacological dementia models
Zsolt K. Bali et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Continuous infusion of the α7 nicotinic acetylcholine receptor agonist EVP-6124 produces no signs of tolerance at memory-enhancing doses in rats: a pharmacokinetic and behavioral study
Nick P. van Goethem et al.
BEHAVIOURAL PHARMACOLOGY (2015)
Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective alpha(7) Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies
Ann J. Barbier et al.
CLINICAL THERAPEUTICS (2015)
The Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor (α7 nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia
Corinne Beinat et al.
CNS DRUGS (2015)
Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease
Jurgita Kuzmickiene et al.
MEDICAL SCIENCE MONITOR (2015)
Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication
William James Deardorff et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys
Henry S. Lange et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
α7 Nicotinic Receptor Agonist Enhances Cognition in Aged 3xTg-AD Mice with Robust Plaques and Tangles
Rodrigo Medeiros et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition: A Proof of Concept, Randomized Trial in Patients with Schizophrenia
Sheldon H. Preskorn et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2014)
Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats
Kelli M. Jones et al.
PSYCHOPHARMACOLOGY (2014)
Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist
Frank G. Boess et al.
PSYCHOPHARMACOLOGY (2013)
Effect of cholinergic neurotransmission modulation on visual spatial paired associate learning in healthy human adults
Brian T. Harel et al.
PSYCHOPHARMACOLOGY (2013)
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors
Jos Prickaerts et al.
NEUROPHARMACOLOGY (2012)
Immediate and Sustained Improvements in Working Memory After Selective Stimulation of alpha 7 Nicotinic Acetylcholine Receptors
Stacy A. Castner et al.
BIOLOGICAL PSYCHIATRY (2011)
Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators
Anatoly A. Mazurov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
RG3487, a Novel Nicotinic alpha 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
Tanya L. Wallace et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Hippocampal dysfunction in patients with mild cognitive impairment: A functional neuroimaging study of a visuospatial paired associates learning task
Mischa de Rover et al.
NEUROPSYCHOLOGIA (2011)
Cognitive Improvement by Activation of alpha(7) Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology
Morten S. Thomsen et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Assessing cognitive function in clinical trials of schizophrenia
Jennifer H. Barnett et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies
Inge Klinkenberg et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Whisker: A client-server high-performance multimedia research control system
Rudolf N. Cardinal et al.
BEHAVIOR RESEARCH METHODS (2010)
A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists
Jerry J. Buccafusco et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes
Simon Sydserff et al.
BIOCHEMICAL PHARMACOLOGY (2009)
TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia
T. A. Hauser et al.
BIOCHEMICAL PHARMACOLOGY (2009)
α7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice
John R. Redrobe et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders
Renza Roncarati et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Effect of R3487/MEM3454, a novel nicotinic α7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats
Amir H. Rezvani et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha 7 nicotinic receptor agonist SSR180711
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2008)
Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys
Jerry J. Buccafusco et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease
Aniko Egerhazi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
SSR180711, a novel selective alpha 7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia
Philippe Pichat et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron:: Role of α7 nicotinic receptors
Kenji Hashimoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Performance of the marmoset monkey on computerized tasks of attention and working memory
S Spinelli et al.
COGNITIVE BRAIN RESEARCH (2004)
Modeling a task that is sensitive to dementia of the Alzheimer's type: individual differences in acquisition of a visuo-spatial paired-associate learning task in rhesus monkeys
MA Taffe et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys
MA Taffe et al.
PSYCHOPHARMACOLOGY (2002)
Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks
R Swainson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2001)
Share Paper
